Analyst firms · Needham · PEN
Needham PEN price target and rating history
Penumbra Inc. (PEN) · Health Care
Needham rates Penumbra Inc. (PEN) Buy with a $326 price target, as of its latest action on Oct 8, 2025. It has published 4 rating actions on PEN since March 2022, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $326
- Median target, all firms
- Too few
- Actions on PEN
- 4
Every Needham rating on PEN
- Oct 8, 2025
- Mar 29, 2023DowngradeNeedham downgrades to Hold from Buy
- Sep 9, 2022
- Mar 8, 2022InitiateNeedham starts coverage at Hold
How other firms rate PEN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $350 | Dec 11, 2025 |
| Wells Fargo | Underweight | $15 | Nov 18, 2025 |
Questions about Needham and PEN
- What is Needham's price target for PEN?
- Needham's latest stated price target for Penumbra Inc. (PEN) is $326, from its action on Oct 8, 2025.
- What is Needham's rating on PEN?
- Needham rates PEN Buy, a bullish rating, as of Oct 8, 2025.
- When did Needham last change its view on PEN?
- On Oct 8, 2025, Needham upgrades to Buy from Hold, price target $326.
More PEN rating histories
All Needham ratingsPEN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.